Radiomultiomics: pioneering precision medicine for severe asthma
European Respiratory Journal · 2024-11 · 64 (5) · 2401639
DOI: 10.1183/13993003.01639-2024 ↗Kurz gefasst
Editorial in der Zeitschrift European Respiratory Journal, online erschienen am 21.11.2024. Verfasst von Francesca Polverino und 1 weiteren Autor:innen. Beteiligte Einrichtung: PCCSM, Baylor College of Medicine, Houston, TX, USA fpolverino@copdnet.org. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben. Gefördert von: National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Extract Asthma and COPD have long been recognised as heterogeneous diseases, characterised by diverse clinical presentations and responses to treatment [1, 2]. Traditional approaches have often relied on a trial-and-error method to identify effective therapies, leading to suboptimal outcomes. However, the integration of omics data (genomics, proteomics, metabolomics, and more) into clinical practice promises to change this paradigm by transforming the approach to managing chronic airway diseases such as asthma and COPD [3]. Central to this transformation is the application of omics technologies which enable a broad and non-hypothesis-driven understanding of the molecular and cellular mechanisms underlying these conditions.
Autor:innen und Institutionen
- PCCSM, Baylor College of Medicine, Houston, TX, USA fpolverino@copdnet.org.
- PCCSM, University of California San Francisco, San Francisco, CA, USA.
Förderung
- National Heart, Lung, and Blood Institute
Zitieren
APA
Polverino, F., & Woodruff, P. G. (2024). Radiomultiomics: pioneering precision medicine for severe asthma. European Respiratory Journal, 64(5), 2401639. https://doi.org/10.1183/13993003.01639-2024
Vancouver
Polverino F, Woodruff PG. Radiomultiomics: pioneering precision medicine for severe asthma. European Respiratory Journal. 2024;64(5):2401639. doi:10.1183/13993003.01639-2024
BibTeX
@article{Polverino2024,
author = {Polverino, Francesca and Woodruff, Prescott G},
title = {Radiomultiomics: pioneering precision medicine for severe asthma},
journal = {European Respiratory Journal},
year = {2024},
volume = {64},
number = {5},
pages = {2401639},
doi = {10.1183/13993003.01639-2024}
}
EUVIMED